New PressureGuard(R) Protocol(TM) Technology Consistent with Span-America's Leadership Role in Pressure Ulcer Prevention and Treatment

Patented Design Which Ensures Airflow Beneath User, and Quieter, Cooler-operating Control Unit Key to New Protocol's High Performance Microclimate Management

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Span-America Protocol air therapy surface

The New PressureGuard(R) Protocol(TM), with high performance microclimate management and alternating pressure therapies.

The new Protocol surface includes several additional features that can be indispensable in modern resident care – gentle alternating pressure therapy to promote improved circulation and healing, and powered flotation treatment modes.

Greenville, SC (PRWEB) June 12, 2014

Span-America recently introduced a new addition to its popular PressureGuard® series of specialty air therapy surfaces. The new PressureGuard Protocol features Span's high performance microclimate management technology, which is indicated for excessive skin moisture caused by perspiration. Excess moisture can lead to maceration, which is a weakening of the skin that can cause pressure ulcers, make them worse, or prevent them from healing. By providing effective skin moisture management, the new offering delivers a highly effective combination of both prevention and treatment of Stage I through IV pressure ulcers. The design of Span's patented direct delivery cover facilitates a gentle flow of air from the quiet, energy efficient control unit.

This operation presents a sharp contrast to typical low air loss systems, whose high output blowers generate more noise and heat while using more power. Vulnerable skin is protected by the uninterrupted flow of air directly to the underside of its vapor-permeable but fluid-proof coverlet, where it interacts with moisture vapor from the user's skin. Moisture vapor is then swept away before it can re-form as a liquid, reducing maceration – an outcome that is especially desirable at the vulnerable sacrum. Unlike typical low air loss designs, the Air Diffusion Matrix fabric is not collapsed by the user's weight, ensuring a pathway for a constant flow of air beneath the user.

The new Protocol surface includes several additional features that can be indispensable in modern resident care – gentle alternating pressure therapy to promote improved circulation and healing, and powered flotation treatment modes which provide additional surface stability for ADLs, transfers, and feeding.

Span's years of development and engineering for the long-term care environment are evident in the PressureGuard platform. It includes features such as the Geo-Matt® style foam topper, a high density, medical grade foam with a geometric design consisting of over 800 individual cells. Each cell acts individually to customize patient support, comfort, and pressure reduction. This segmentation minimizes the pulling of the skin and tissue over bony prominences, offsetting the harmful effects of shearing. The Heel Slope™ at the topper's foot end is designed to further reduce pressure at the sensitive heel.

Another PressureGuard feature with multiple advantages is the Safety Edge™, which helps prevent falls and user entrapment between the side-rail and the mattress. The two-part foam bolster system provides a firmer surface for edge-of-bed sitting and encourages the supine user towards the center of the mattress, increasing compliance with bed safety guidelines.

About Span-America Medical Systems, Inc.
Span-America (http://www.spanamerica.com) manufactures and markets a comprehensive selection of pressure management products, beds and furniture for the medical market, including PressureGuard®, Geo-Mattress®, Geo-Matt®, Span+Aids®, Selan® and MC Healthcare products. The company also supplies custom foam and packaging products to the consumer and industrial markets. Span-America's stock is traded on The NASDAQ Stock Market's National Market under the symbol "SPAN".